Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Thiazovivin and the Future of Cellular Plasticity: Mechan...
2025-10-21
Explore how Thiazovivin, a high-purity ROCK inhibitor, is revolutionizing stem cell research by enhancing cell survival, reprogramming efficiency, and enabling precision modulation of cellular plasticity. This thought-leadership article connects leading-edge mechanistic science with pragmatic guidance for translational researchers, offering a vision for the next generation of regenerative medicine and disease modeling.
-
Thiazovivin and the Epigenetic Frontier: Expanding ROCK I...
2025-10-20
Explore how Thiazovivin, a potent ROCK inhibitor, uniquely integrates with emerging epigenetic insights to enable precise manipulation of cellular plasticity in stem cell research. Delve into advanced mechanisms and translational frontiers that set this cornerstone apart.
-
Thiazovivin and the Next Generation of Cellular Plasticit...
2025-10-19
This thought-leadership article explores Thiazovivin—a potent ROCK inhibitor—as a transformative tool in stem cell research and regenerative medicine. By weaving together mechanistic understanding, experimental best practices, clinical implications, and forward-looking strategy, we offer translational researchers actionable insight into leveraging Thiazovivin for enhanced cell reprogramming, stem cell survival, and the advancement of differentiation therapy. Integrating recent findings in cancer cell plasticity and epigenetic modulation, we chart new frontiers beyond standard product narratives, linking ROCK inhibition to emerging paradigms in disease modeling and therapeutic innovation.
-
Thiazovivin: Advanced Strategies for ROCK Pathway Modulat...
2025-10-18
Explore how Thiazovivin, a potent ROCK inhibitor, enables unprecedented control over cell fate and survival in stem cell research. This article unveils novel insights into ROCK signaling modulation, fibroblast reprogramming enhancement, and the convergence of epigenetics and cellular plasticity.
-
Paclitaxel (Taxol) in Translational Oncology: Mechanistic...
2025-10-17
This thought-leadership article explores the multifaceted role of Paclitaxel (Taxol) as a microtubule polymer stabilizer, from its foundational mechanistic action to its transformative impact on cancer and peripheral neuropathy models. We connect advanced mechanistic understanding, translational strategies, and competitive positioning, while projecting a visionary outlook for researchers aspiring to innovate at the intersection of oncology and neuroprotection.
-
DAPI (hydrochloride): Illuminating Cell Fate in Organoid ...
2025-10-16
This thought-leadership article delves into the mechanistic underpinnings and strategic deployment of DAPI (hydrochloride) in advanced organoid research. Integrating critical findings from recent breakthroughs in human intestinal organoid systems, we explore how the precise DNA-specific fluorescence of DAPI empowers researchers to decode self-renewal and differentiation dynamics, optimize high-throughput workflows, and drive translational innovation. Going beyond standard product descriptions, this guide offers actionable advice, competitive context, and a visionary outlook for the next generation of stem cell and organoid studies.
-
Tamoxifen: Precision SERM for Gene Knockout & Translation...
2025-10-15
Tamoxifen stands out as a selective estrogen receptor modulator enabling precise CreER-mediated gene knockout, advanced cancer and antiviral studies, and targeted protein kinase C inhibition. Explore stepwise workflows, comparative advantages, and troubleshooting strategies to maximize research impact across immunology, virology, and oncology.
-
br Future directions outlook Peptide based
2023-07-05
Future directions-outlook Peptide-based macrocycles are among the privileged scaffolds in antibiotic drug discovery. Many compounds were discovered by natural product screening and developed unchanged, or as semi-synthetic derivatizations. Since the golden age of antibiotic discovery (1940s-mid 1
-
However joint reviews and the consensus from experts offer
2023-07-05
However, joint reviews and the consensus from experts offer disparate recommendations with regard to their management in the context of anesthesia, whereas some reviews [6], [7] set out certain doubts regarding their use during the perioperative period. On the other hand, the guidelines for the mana
-
Thus we presumed that ALDH A
2023-07-05
Thus, we presumed that ALDH1A3 might play an important role in TMZ-chemoresistance in glioblastoma patients. As we expected, the glioblastoma cell lines and primary glioma Tolvaptan were more sensitive to TMZ treatment when ALDH1A3 was inhibited or depleted. Consistently, it has been shown that down
-
br Distribution of OCT in rat
2023-07-05
Distribution of OCT3 in rat brain To understand the potential roles of this corticosterone-sensitive monoamine clearance mechanism in the regulation of monoaminergic neurotransmission and behavior, and its potential contribution to corticosteroid actions on behavior, we examined the rostrocaudal
-
There are two ways to transport FFAs
2023-07-05
There are two ways to transport FFAs into cells. First by passive diffusion. Second as the putative long-chain fatty teva 3026 mg transporters are proposed, CD36 the plasma membrane-associated fatty acid-binding protein (FABPpm) and fatty acid transport proteins (FATP) [11], where CD36 is responsib
-
The biology of the A
2023-07-05
The biology of the A2BR is complex and needs to be considered contextually as the expression and effect of receptor engagement varies according to time post hypoxic injury, cell type and downstream signaling pathway. For example, A2BR expression is dynamic - low under basal and increasing under isch
-
sVRPs were more sensitive to ABT than MSRs This result
2023-07-05
sVRPs were more sensitive to ABT-702 than MSRs. This result agrees with previous reports that the activation of A1 receptors more potently inhibits sVRPs than MSRs (Nakamura et al., 1997, Otsuguro et al., 2009). Importantly, sVRPs are thought to reflex C-fiber-evoked nociceptive transmission. Nocice
-
A review has recently been published to evaluate the potenti
2023-07-05
A review has recently been published to evaluate the potential effects of food, alcohol and SC75741 juices on the pharmacokinetics and pharmacodynamics of the drugs for BPH. The authors reviewed the PubMed database during the years 1991–2015. In addition, a digital version of Stockley on drug intera
10142 records 13/677 page Previous Next First page 上5页 1112131415 下5页 Last page